Eurobio Scientific: full-year revenues up 17% to €59.1M

by NASDAQ Market News January 27, 2020

NASDAQ Market News
Click here to email author

Surface Oncology Announces FDA Clearance of SRF617 and SRF388 INDs to Initiate Phase 1 Clinical Trials

GeoVax and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine

Ads